We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Mimetic Promotes Blood Vessel Relaxation

By Biotechdaily staff writers
Posted on 19 May 2003
Researchers have found that a mimetic of the last protein in a complex signaling pathway, HSP20, can relax smooth muscle cells and may lead to the development of a drug that promotes blood vessel relaxation, preventing dangerous spasms. More...
The finding was reported in the May 8, 2003, online edition of the Journal of the FASEB (Federation of American Society for Experimental Biology).

The signaling pathway that causes relaxation in smooth muscle cells involves many different proteins, but the last step is the phosphorylation of HSP20. Molecules have been developed that affect earlier steps in the pathway, but these are ineffective if a problem occurs later. Severe spasm of blood vessels contributes to the failure of bypass surgeries and to strokes following the rupture of an aneurysm in the brain.

The mimetic was developed by researchers at Arizona State University (ASU, Tempe, USA). It consists of a 13-amino acid stretch of the protein attached to a protein transduction domain, a peptide that allows the mimetic to enter cells. In pigs, the mimetic caused the rings of muscle to relax in a dose-dependent fashion. Mass spectrometry confirmed that the mimetic induced relaxation by its own action.

"You've got all those signaling pathways, but, boom, you can bypass them by putting in a mimetic of the protein that's the effector molecule,” said primary investigator Colleen Brophy, research professor of bioengineering at ASU.




Related Links:
Arizona State University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.